MedPath

Endometrial Injury and Single Embryo Transfer

Not Applicable
Completed
Conditions
Primary Infertility
Interventions
Device: Endometrial injury
Registration Number
NCT01851876
Lead Sponsor
Karadeniz Technical University
Brief Summary

Endometrial injury increases clinical pregnancy rate in normoresponder patients undergoing long agonist protocol intracytoplasmic sperm injection cycles with single embryo transfer.

Detailed Description

Endometrial injury means endometrial biopsy on day 3 of menstrual cycle following down regulation in an IVF patient.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
118
Inclusion Criteria
  • woman age under 35 years
  • history of primary infertility
  • normoresponder (antral follicle count 5-10 in one ovary in early follicular phase
  • having grade I or II embryos for transfer
  • agree to undergo endometrial biopsy during the COH cycle. All patients were stimulated with luteal phase long protocol.
Exclusion Criteria
  • endocrinopathies (including diabetes mellitus, hyperprolactinemia, Cushing's disease, and congenital adrenal hyperplasia), any systemic disease, collagen disorder, hypercholesterolemia, sickle cell anemia, and a history of neoplasm; -high risk for or history of OHSS
  • using any concurrent medication (e.g., insulin-sensitizing drugs, and GnRH antagonists)
  • patients who did not proceed to follicle retrieval
  • severe male infertility requiring TESA/TESA
  • mullerian tract anomalies
  • a history of endometrial instrumentation or surgery within a month of the study
  • not agree to undergo endometrial biopsy during the COH cycle.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Endometrial injuryEndometrial injuryThe patients in this group will be subjected to endometrial injury procedure in preceding IVF cycle.
Primary Outcome Measures
NameTimeMethod
Clinical Pregnancy Rate4 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath